Advertisement

Topics

Takeda San Francisco, Inc. Company Profile

16:26 EDT 22nd September 2017 | BioPortfolio

Takeda San Francisco, Inc. (TSF), established in November 2007 as a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Osaka, Japan, is Takeda's Biologics Center of Excellence and Antibody IND Engine for human antibody therapeutics for the treatment of cancer, inflammation and metabolic diseases. TSF supports Takeda's therapeutic antibody initiative in close collaboration with Takeda's other R&D organizations. Additional information about Takeda San Francisco is available at http://www.takedasf.com.


News Articles [673 Associated News Articles listed on BioPortfolio]

Nektar and Takeda Enter Research Deal Exploring Combination Cancer Therapy Approaches

SAN FRANCISCO, May 22, 2017 /PRNewswire/ — Nektar Therapeutics (NASDAQ: NKTR) announced today that Takeda Pharmaceutical Company Limited (TSE: 4502) and Nektar have entered into a research colla...

Takeda and Abingworth invest $100mm in GammaDelta Therapeutics; Takeda has option to buy

Takeda Pharmaceutical Co. Ltd., through its Millennium Pharmaceuticals/Takeda Oncology unit, and Abingworth agreed to together commit up to $100mm in funding to Abingworth-seeded biotech GammaDelta Th...

Takeda and Shattuck Labs Announce Research Collaboration to Explore Agonist Redirected ...

Takeda Contact:Kelly Schlemm – USAkelly.schlemm@takeda.com+1-617-551-8865orShattuck Contact:Josiah Hornblowerjhornblower@shattucklabs.com Read more...

Takeda options programs discovered through Schrodinger alliance

Takeda Pharmaceutical Co. Ltd. and drug discovery firm Schrodinger Inc. penned a multi-year, multi-target deal focused on Takeda’s core therapy areas.

Nektar and Takeda enter into trial collaboration for myeloma, lymphoma, and colorectal cancer

Nektar Therapeutics and Takeda Pharmaceutical Co. Ltd., through its Takeda Oncology/Millennium Pharmaceuticals division, entered into a trial collaboration to explore the combination of Nektar’s NKT...

Takeda and Molecular Templates Announce Multi-Target Research and...

The collaboration will apply Molecular Templates' engineered toxin bodies technology platform to potential therapeutic targets provided by Takeda through a joint scientific committee of both compa...

HitGen, Takeda enter DNA-encoded library based drug discovery research collaboration

HitGen announced that the company has entered into a research collaboration with Takeda Pharmaceutical Company to discover novel small molecule leads for multiple targets in Takeda’s therapeutic are...

Takeda, Stanford University announce alliance

Takeda Pharmaceutical has announced a collaboration with Stanford University to form the Stanford Alliance for Innovative Medicines (Stanford AIM), which will help transform novel Stanford research in...

PubMed Articles [39 Associated PubMed Articles listed on BioPortfolio]

Video Comment on Kenichi Takeda et al.

Deep nirS amplicon sequencing of San Francisco Bay sediments enables prediction of geography and environmental conditions from denitrifying community composition.

Denitrification is a dominant nitrogen loss process in the sediments of San Francisco Bay. In this study, we sought to understand the ecology of denitrifying bacteria by using next-generation sequenci...

Short-Term Effects of Early Switching to Ranibizumab or Aflibercept in Diabetic Macular Edema Cases With Non-Response to Bevacizumab.

To study the effect of early switching to ranibizumab (Lucentis; Genentech, South San Francisco, CA) or aflibercept (Eylea; Regeneron, Tarrytown, NY) in cases of diabetic macular edema (DME) that have...

Stable C and N isotope analysis of hair suggest undernourishment as a factor in the death of a mummified girl from late 19th century San Francisco, CA.

The chance discovery of a 1.5-3.5 years old mummified girl presents a unique opportunity to further our understanding of health and disease among children in 19th Century San Francisco. This study foc...

Water quality measurements in San Francisco Bay by the U.S. Geological Survey, 1969-2015.

The U.S. Geological Survey (USGS) maintains a place-based research program in San Francisco Bay (USA) that began in 1969 and continues, providing one of the longest records of water-quality measuremen...

Clinical Trials [60 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Dexlansoprazole Capsules From Two Manufacturing Plants

The purpose of this study is to assess the bioavailability of dexlansoprazole from a 30 milligram (mg) or 60 mg delayed-release capsule manufactured at Takeda GmbH Plant Oranienburg, Germa...

Validation of the San Francisco Syncope Rule

This study was designed to validate the "San Francisco Syncope Rule". This set of rules was derived by Quinn et. al. to help guide the treatment of patients evaluated in the Emergency Dep...

A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Dexlansoprazole from Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant...

The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender Community

The Stay Study is a multi-site, open-label HIV pre-exposure prophylaxis (PrEP) demonstration project for advancing PrEP delivery in the San Francisco Bay Area Transgender Community. Approx...

Evaluation of the Healthy Apple Program in San Francisco

This randomized controlled trial uses administrative public health screening data to test whether the Healthy Apple program (HAP), designed to support local implementation of national Let'...

Companies [484 Associated Companies listed on BioPortfolio]

Takeda San Francisco, Inc.

Takeda San Francisco, Inc. (TSF), established in November 2007 as a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Osaka, Japan, is Takeda's Biologics Center of Excellence and Antib...

Takeda San Francisco Inc.

Takeda San Francisco was established in November 2007 and supports Takeda's therapeutic antibody research aiming to build antibody technology platforms based on technologies such as discovery and ...

Takeda Pharmaceuticals International, Inc.

Located in Deerfield, Illinois, Takeda Pharmaceuticals International, Inc. is a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited, an industry leader and the larges...

Takeda Oncology

Takeda Oncology, headquartered in Cambridge, MA, delivers novel medicines to patients with cancer worldwide through its commitment to science, breakthrough innovation and passion ...

Takeda Pharmaceuticals Company Limited

Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global lea...

More Information about "Takeda San Francisco, Inc." on BioPortfolio

We have published hundreds of Takeda San Francisco, Inc. news stories on BioPortfolio along with dozens of Takeda San Francisco, Inc. Clinical Trials and PubMed Articles about Takeda San Francisco, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Takeda San Francisco, Inc. Companies in our database. You can also find out about relevant Takeda San Francisco, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record